{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:24:50Z","timestamp":1789687490805,"version":"4.0.1"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019417","name":"Pittsburgh Liver Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P30DK120531"],"award-info":[{"award-number":["1P30DK120531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PF 2019-05"],"award-info":[{"award-number":["PF 2019-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PF 2022-04"],"award-info":[{"award-number":["PF 2022-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA258449"],"award-info":[{"award-number":["1R01CA258449"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pharmthera.2022.108334","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T20:17:00Z","timestamp":1671221820000},"page":"108334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["DNA methylation in cell plasticity and malignant transformation in liver diseases"],"prefix":"10.1016","volume":"241","author":[{"given":"Minwook","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108334_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.643055","article-title":"Epigenetic regulation of cell-fate changes that determine adult liver regeneration after injury","volume":"9","author":"Aloia","year":"2021","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0010","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41556-019-0402-6","article-title":"Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration","volume":"21","author":"Aloia","year":"2019","journal-title":"Nature Cell Biology"},{"issue":"18","key":"10.1016\/j.pharmthera.2022.108334_bb0015","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1158\/0008-5472.CAN-07-1720","article-title":"Mastermind-like 1 is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival","volume":"67","author":"Alves-Guerra","year":"2007","journal-title":"Cancer Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4161\/epi.22191","article-title":"Novel target genes and a valid biomarker panel identified for cholangiocarcinoma","volume":"7","author":"Andresen","year":"2012","journal-title":"Epigenetics"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0025","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.27707","article-title":"Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma","volume":"61","author":"Andresen","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216374","article-title":"LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype","volume":"14","author":"Anwar","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcdb.2019.03.004","article-title":"Chromatin dynamics during liver regeneration","volume":"97","author":"Arechederra","year":"2020","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"7214","key":"10.1016\/j.pharmthera.2022.108334_bb0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature07249","article-title":"Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism","volume":"455","author":"Arita","year":"2008","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.pharmthera.2022.108334_bb0045","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1073\/pnas.1203701109","article-title":"Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1","volume":"109","author":"Arita","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108334_bb0050","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.7150\/jca.52378","article-title":"Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression","volume":"12","author":"Armartmuntree","year":"2021","journal-title":"Journal of Cancer"},{"issue":"7214","key":"10.1016\/j.pharmthera.2022.108334_bb0055","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature07273","article-title":"Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1","volume":"455","author":"Avvakumov","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000484104","article-title":"Long interspersed element-1 methylation level as a prognostic biomarker in gastrointestinal cancers","volume":"97","author":"Baba","year":"2018","journal-title":"Digestion"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0065","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hep.31486","article-title":"Ten-eleven translocation 1 promotes malignant progression of cholangiocarcinoma with wild-type isocitrate dehydrogenase 1","volume":"73","author":"Bai","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30168","article-title":"Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma","volume":"69","author":"Barcena-Varela","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13148-021-01131-4","article-title":"Epigenetic reprogramming of cell identity: Lessons from development for regenerative medicine","volume":"13","author":"Basu","year":"2021","journal-title":"Clinical Epigenetics"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2022.108334_bb0080","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ncponc0354","article-title":"DNA methylation and gene silencing in cancer","volume":"2","author":"Baylin","year":"2005","journal-title":"Nature Clinical Practice. Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2019.03.007","article-title":"A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets","volume":"71","author":"Bayo","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pharmtox-010716-105106","article-title":"Targeting epigenetics in cancer","volume":"58","author":"Bennett","year":"2018","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"6083","key":"10.1016\/j.pharmthera.2022.108334_bb0095","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1220671","article-title":"Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution","volume":"336","author":"Booth","year":"2012","journal-title":"Science"},{"issue":"5845","key":"10.1016\/j.pharmthera.2022.108334_bb0100","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1147939","article-title":"UHRF1 plays a role in maintaining DNA methylation in mammalian cells","volume":"317","author":"Bostick","year":"2007","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0105","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"Braconi","year":"2010","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.pharmthera.2022.108334_bb0110","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Cancer Genome Atlas Research Network. Electronic address, w. b. e. and N. Cancer Genome Atlas Research","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0120","doi-asserted-by":"crossref","first-page":"8978930","DOI":"10.1155\/2020\/8978930","article-title":"The DNMT1\/miR-34a\/FOXM1 axis contributes to stemness of liver cancer cells","volume":"2020","author":"Cao","year":"2020","journal-title":"Journal of Oncology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108334_bb0125","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.cgh.2020.08.065","article-title":"A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma","volume":"19","author":"Chalasani","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fgene.2014.00019","article-title":"Epigenetic inheritance of cell fates during embryonic development","volume":"5","author":"Cheedipudi","year":"2014","journal-title":"Frontiers in Genetics"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0135","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.31561","article-title":"DNA methylation of cannabinoid receptor interacting protein 1 promotes pathogenesis of intrahepatic cholangiocarcinoma through suppressing parkin-dependent pyruvate kinase M2 ubiquitination","volume":"73","author":"Chen","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0140","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.2147\/OTT.S203342","article-title":"Five hub genes can be the potential DNA methylation biomarkers for cholangiocarcinoma using bioinformatics analysis","volume":"12","author":"Chen","year":"2019","journal-title":"Oncotargets and Therapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12094-019-02140-9","article-title":"Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21","volume":"22","author":"Chen","year":"2020","journal-title":"Clinical & Translational Oncology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.142","article-title":"MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-biochem-103019-102815","article-title":"Role of mammalian DNA methyltransferases in development","volume":"89","author":"Chen","year":"2020","journal-title":"Annual Review of Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0160","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0165","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2013.10.019","article-title":"Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish","volume":"146","author":"Choi","year":"2014","journal-title":"Gastroenterology"},{"issue":"5334","key":"10.1016\/j.pharmthera.2022.108334_bb0170","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1126\/science.277.5334.1996","article-title":"Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1","volume":"277","author":"Chuang","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13046-022-02394-2","article-title":"The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease","volume":"41","author":"Cigliano","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"38","key":"10.1016\/j.pharmthera.2022.108334_bb0180","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1073\/pnas.1704961114","article-title":"Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers","volume":"114","author":"Cohen","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0185","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/hep.31642","article-title":"Dual targeting of G9a and DNA methyltransferase-1 for the treatment of experimental cholangiocarcinoma","volume":"73","author":"Colyn","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0190","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes & Development"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.stem.2018.05.022","article-title":"Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes","volume":"23","author":"Deng","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108334_bb0200","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1101\/gad.929101","article-title":"Lsh, a member of the SNF2 family, is required for genome-wide methylation","volume":"15","author":"Dennis","year":"2001","journal-title":"Genes & Development"},{"issue":"17","key":"10.1016\/j.pharmthera.2022.108334_bb0205","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1093\/nar\/gkf509","article-title":"Dnmt3L is a transcriptional repressor that recruits histone deacetylase","volume":"30","author":"Deplus","year":"2002","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0210","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/theoncologist.2012-0465","article-title":"Concise drug review: azacitidine and decitabine","volume":"18","author":"Derissen","year":"2013","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0215","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00432-020-03219-5","article-title":"Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas","volume":"146","author":"Dhayat","year":"2020","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0220","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nsmb.1476","article-title":"De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes","volume":"15","author":"Epsztejn-Litman","year":"2008","journal-title":"Nature Structural & Molecular Biology"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108334_bb0225","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1101\/gad.1463706","article-title":"Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication","volume":"20","author":"Esteve","year":"2006","journal-title":"Genes & Development"},{"issue":"16","key":"10.1016\/j.pharmthera.2022.108334_bb0230","first-page":"5021","article-title":"Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma","volume":"63","author":"Farazi","year":"2003","journal-title":"Cancer Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0235","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2019-320282","article-title":"Liquid biopsy in the clinical management of hepatocellular carcinoma","volume":"69","author":"von Felden","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0240","article-title":"Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg","volume":"2","author":"Fernandez-Barrena","year":"2020","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006052","article-title":"Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model","volume":"14","author":"Folguera-Blasco","year":"2018","journal-title":"PLoS Computational Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/71750","article-title":"DNA methyltransferase Dnmt1 associates with histone deacetylase activity","volume":"24","author":"Fuks","year":"2000","journal-title":"Nature Genetics"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0255","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/emboj\/20.10.2536","article-title":"Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription","volume":"20","author":"Fuks","year":"2001","journal-title":"The EMBO Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0260","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.stem.2020.08.016","article-title":"Epithelial plasticity during liver injury and regeneration","volume":"27","author":"Gadd","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0265","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.humpath.2014.01.016","article-title":"IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma","volume":"45","author":"Gao","year":"2014","journal-title":"Human Pathology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0270","first-page":"7591","article-title":"Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma","volume":"13","author":"Ge","year":"2021","journal-title":"American Journal of Translational Research"},{"issue":"24","key":"10.1016\/j.pharmthera.2022.108334_bb0275","doi-asserted-by":"crossref","first-page":"25447","DOI":"10.1074\/jbc.M312296200","article-title":"Chromatin targeting of de novo DNA methyltransferases by the PWWP domain","volume":"279","author":"Ge","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0280","doi-asserted-by":"crossref","first-page":"11512","DOI":"10.1038\/s41598-022-15058-0","article-title":"DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies","volume":"12","author":"Goncalves","year":"2022","journal-title":"Scientific Reports"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0285","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"7536","key":"10.1016\/j.pharmthera.2022.108334_bb0290","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature13899","article-title":"Structural insight into autoinhibition and histone H3-induced activation of DNMT3A","volume":"517","author":"Guo","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0295","article-title":"Epigenetics of alcohol-related liver diseases","volume":"4","author":"Habash","year":"2022","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0300","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/s41467-018-03999-y","article-title":"Epigenetic landscape influences the liver cancer genome architecture","volume":"9","author":"Hama","year":"2018","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0305","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.stemcr.2019.01.010","article-title":"Lineage tracing reveals the bipotency of SOX9(+) hepatocytes during liver regeneration","volume":"12","author":"Han","year":"2019","journal-title":"Stem Cell Reports"},{"issue":"17","key":"10.1016\/j.pharmthera.2022.108334_bb0310","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1158\/1078-0432.CCR-18-4010","article-title":"A phase Ib\/II study of ramucirumab in combination with emibetuzumab in patients with advanced cancer","volume":"25","author":"Harding","year":"2019","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0315","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"issue":"7214","key":"10.1016\/j.pharmthera.2022.108334_bb0320","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nature07280","article-title":"The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix","volume":"455","author":"Hashimoto","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0325","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/j.gastro.2013.11.045","article-title":"Regeneration of liver after extreme hepatocyte loss occurs mainly via biliary transdifferentiation in zebrafish","volume":"146","author":"He","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41536-022-00217-8","article-title":"DNA methylation maintenance at the p53 locus initiates biliary-mediated liver regeneration","volume":"7","author":"He","year":"2022","journal-title":"NPJ Regen Med"},{"issue":"6047","key":"10.1016\/j.pharmthera.2022.108334_bb0335","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","article-title":"Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41588-018-0274-x","article-title":"Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions","volume":"51","author":"Heyn","year":"2019","journal-title":"Nature Genetics"},{"issue":"19","key":"10.1016\/j.pharmthera.2022.108334_bb0345","doi-asserted-by":"crossref","first-page":"9425","DOI":"10.18632\/oncotarget.2444","article-title":"Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis","volume":"5","author":"Hlady","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0350","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(01)00280-X","article-title":"Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene","volume":"104","author":"Howell","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0355","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: Mechanism and clinical application","volume":"13","author":"Hu","year":"2021","journal-title":"Clinical Epigenetics"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0365","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.gastro.2022.05.007","article-title":"NOTCH-YAP1\/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma","volume":"163","author":"Hu","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3727\/105221621X16111780348794","article-title":"Wnt\/-catenin signaling and liver regeneration: Circuit, biology, and opportunities","volume":"20","author":"Hu","year":"2021","journal-title":"Gene Expression"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0375","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/hep.27285","article-title":"Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model","volume":"60","author":"Huang","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0380","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhep.2021.04.033","article-title":"Dysregulation of the ESRP2-NF2-YAP\/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease","volume":"75","author":"Hyun","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0385","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.298","article-title":"The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores","volume":"41","author":"Irizarry","year":"2009","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0390","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.molcel.2017.09.037","article-title":"Structure of the Dnmt1 reader module complexed with a unique two-mono-ubiquitin mark on histone H3 reveals the basis for DNA methylation maintenance","volume":"68","author":"Ishiyama","year":"2017","journal-title":"Molecular Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2022.108334_bb0395","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000167859","article-title":"Epigenetic alterations in cholangiocarcinoma-sustained IL-6\/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing","volume":"79","author":"Isomoto","year":"2009","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0400","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.gastro.2006.10.037","article-title":"Sustained IL-6\/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing","volume":"132","author":"Isomoto","year":"2007","journal-title":"Gastroenterology"},{"issue":"7310","key":"10.1016\/j.pharmthera.2022.108334_bb0405","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","article-title":"Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"issue":"6047","key":"10.1016\/j.pharmthera.2022.108334_bb0410","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb0415","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/exd.14108","article-title":"Methylation patterns of cutaneous T-cell lymphomas","volume":"30","author":"Izykowska","year":"2020","journal-title":"Experimental Dermatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0420","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12885-017-3595-8","article-title":"Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma","volume":"17","author":"Jeong","year":"2017","journal-title":"BMC Cancer"},{"issue":"7159","key":"10.1016\/j.pharmthera.2022.108334_bb0425","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature06146","article-title":"Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation","volume":"449","author":"Jia","year":"2007","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0430","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15592294.2016.1214781","article-title":"Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma","volume":"11","author":"Jueliger","year":"2016","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0435","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hep.31679","article-title":"Farnesoid X receptor activation impairs liver progenitor cell-mediated liver regeneration via the PTEN-PI3K-AKT-mTOR axis in zebrafish","volume":"74","author":"Jung","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0440","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discovery"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0445","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5858\/2007-131-923-MPOMCI","article-title":"Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas","volume":"131","author":"Kim","year":"2007","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0450","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00428-018-02511-7","article-title":"DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype","volume":"475","author":"Kim","year":"2019","journal-title":"Virchows Archiv"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0455","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2015.10.017","article-title":"Bromodomain and extraterminal (BET) proteins regulate biliary-driven liver regeneration","volume":"64","author":"Ko","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0460","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/bs.acr.2022.02.003","article-title":"YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma","volume":"156","author":"Ko","year":"2022","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-pathmechdis-012419-032824","article-title":"Liver progenitors and adult cell plasticity in hepatic injury and repair: Knowns and unknowns","volume":"15","author":"Ko","year":"2019","journal-title":"Annual Review of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0470","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.gastro.2018.09.039","article-title":"Hdac1 regulates differentiation of bipotent liver progenitor cells during regeneration via Sox9b and Cdk8","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0475","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ccell.2019.03.003","article-title":"Defining UHRF1 domains that support maintenance of human colon cancer DNA methylation and oncogenic properties","volume":"35","author":"Kong","year":"2019","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108334_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002384","article-title":"Repetitive elements may comprise over two-thirds of the human genome","volume":"7","author":"de Koning","year":"2011","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650473","article-title":"Mechanisms of action of hypomethylating agents: Endogenous retroelements at the epicenter","volume":"11","author":"Kordella","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"5929","key":"10.1016\/j.pharmthera.2022.108334_bb0490","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","article-title":"The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain","volume":"324","author":"Kriaucionis","year":"2009","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108334_bb0495","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.molonc.2015.06.002","article-title":"Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin","volume":"9","author":"Kuang","year":"2015","journal-title":"Molecular Oncology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Advances in Genetics"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0505","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.bbadis.2018.08.012","article-title":"Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN\/AKT pathway","volume":"1864","author":"Kumar","year":"2018","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0510","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/carcin\/bgx005","article-title":"Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: Comparison with hepatitis virus-related carcinogenesis","volume":"38","author":"Kuramoto","year":"2017","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0515","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12876-022-02360-4","article-title":"Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma","volume":"22","author":"Kurokawa","year":"2022","journal-title":"BMC Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0520","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/hep.31800","article-title":"Stress-responsive gene FK506-binding protein 51 mediates alcohol-induced liver injury through the hippo pathway and chemokine (C-X-C motif) ligand 1 Signaling","volume":"74","author":"Kusumanchi","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0525","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0888-7543(92)90024-M","article-title":"CpG islands as gene markers in the human genome","volume":"13","author":"Larsen","year":"1992","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0530","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: A consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"6097","key":"10.1016\/j.pharmthera.2022.108334_bb0535","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1222077","article-title":"Landscape of somatic retrotransposition in human cancers","volume":"337","author":"Lee","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0540","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-9440(10)64262-9","article-title":"Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma","volume":"161","author":"Lee","year":"2002","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0545","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019133","article-title":"DNA methylation in mammals","volume":"6","author":"Li","year":"2014","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0550","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","article-title":"YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis","volume":"24","author":"Li","year":"2022","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0555","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/hep.29116","article-title":"MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0560","first-page":"2768","article-title":"LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1","volume":"23","author":"Li","year":"2019","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0565","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1093\/nar\/gky104","article-title":"Structural and mechanistic insights into UHRF1-mediated DNMT1 activation in the maintenance DNA methylation","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0570","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2019.06.008","article-title":"A homeostatic Arid1a-dependent permissive chromatin state licenses hepatocyte responsiveness to liver-injury-associated YAP signaling","volume":"25","author":"Li","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0575","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1053\/j.gastro.2008.07.027","article-title":"Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: Methylation of the E-cadherin promoter","volume":"135","author":"Lim","year":"2008","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2022.108334_bb0580","first-page":"41","article-title":"Epigenetic aberrations in cholangiocarcinoma: Potential biomarkers and promising target for novel therapeutic strategies","volume":"13","author":"Limpaiboon","year":"2012","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0585","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2004.06.020","article-title":"Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma","volume":"217","author":"Limpaiboon","year":"2005","journal-title":"Cancer Letters"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0590","doi-asserted-by":"crossref","first-page":"492","DOI":"10.21037\/tlcr.2016.10.03","article-title":"Methylation analyses in liquid biopsy","volume":"5","author":"Lissa","year":"2016","journal-title":"Transl Lung Cancer Res"},{"issue":"37","key":"10.1016\/j.pharmthera.2022.108334_bb0595","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.1612262113","article-title":"Vitamin C increases viral mimicry induced by 5-aza-2\u2032-deoxycytidine","volume":"113","author":"Liu","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0600","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.30091","article-title":"Integrative epigenetic analysis reveals therapeutic targets to the DNA methyltransferase inhibitor guadecitabine (SGI-110) in hepatocellular carcinoma","volume":"68","author":"Liu","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0605","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tranon.2018.01.023","article-title":"Methylation-mediated silencing of GATA5 gene suppresses cholangiocarcinoma cell proliferation and metastasis","volume":"11","author":"Liu","year":"2018","journal-title":"Translational Oncology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0610","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5356","article-title":"Pancancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors","volume":"60","author":"Liu","year":"2022","journal-title":"International Journal of Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0615","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/147323001204000107","article-title":"Targeted drug regulation on methylation of p53-BAX mitochondrial apoptosis pathway affects the growth of cholangiocarcinoma cells","volume":"40","author":"Liu","year":"2012","journal-title":"The Journal of International Medical Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0620","first-page":"407","article-title":"Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma","volume":"6","author":"Liu","year":"2007","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0625","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jgg.2017.11.006","article-title":"Genetic profiling of cancer with circulating tumor DNA analysis","volume":"45","author":"Lu","year":"2018","journal-title":"Journal of Genetics and Genomics"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb0630","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ncb3203","article-title":"Hepatic progenitor cells of biliary origin with liver repopulation capacity","volume":"17","author":"Lu","year":"2015","journal-title":"Nature Cell Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb0635","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tig.2020.05.002","article-title":"Unraveling the epigenetic basis of liver development, regeneration and disease","volume":"36","author":"Macchi","year":"2020","journal-title":"Trends in Genetics"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0640","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jhep.2019.02.003","article-title":"Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury","volume":"70","author":"Manco","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0645","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201700137","article-title":"How Polycomb-mediated cell memory deals with a changing environment: Variations in PcG complexes and proteins assortment convey plasticity to epigenetic regulation as a response to environment","volume":"40","author":"Marasca","year":"2018","journal-title":"Bioessays"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0650","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/j.gastro.2016.09.001","article-title":"IGF2 is up-regulated by epigenetic mechanisms in hepatocellular carcinomas and is an actionable oncogene product in experimental models","volume":"151","author":"Martinez-Quetglas","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0655","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2019.04.015","article-title":"Tailored chromatin modulation to promote tissue regeneration","volume":"97","author":"Martinez-Redondo","year":"2020","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108334_bb0660","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/jmv.25221","article-title":"Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population","volume":"90","author":"Maryam","year":"2018","journal-title":"Journal of Medical Virology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9010005","article-title":"Circulating nucleosomes and nucleosome modifications as biomarkers in cancer","volume":"9","author":"McAnena","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108334_bb0670","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/1078-0432.CCR-08-2784","article-title":"Cancer DNA methylation: Molecular mechanisms and clinical implications","volume":"15","author":"McCabe","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0675","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.onc.1210648","article-title":"Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes","volume":"27","author":"Meng","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0680","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2017.02.017","article-title":"SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma","volume":"67","author":"Merino-Azpitarte","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0685","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.31704","article-title":"Dynamic transcriptional and epigenetic changes drive cellular plasticity in the liver","volume":"74","author":"Merrell","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0690","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/hep.28988","article-title":"Hepatostat: Liver regeneration and normal liver tissue maintenance","volume":"65","author":"Michalopoulos","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0695","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: Biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"688","key":"10.1016\/j.pharmthera.2022.108334_bb0700","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay9185","article-title":"Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation","volume":"14","author":"Minnis-Lyons","year":"2021","journal-title":"Science Signaling"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00324","article-title":"Circulating tumor DNA profiling of advanced biliary tract cancers","volume":"3","author":"Mody","year":"2019","journal-title":"JCO Precision Oncology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0710","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"Beta-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0715","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg.2016.98","article-title":"Transition states and cell fate decisions in epigenetic landscapes","volume":"17","author":"Moris","year":"2016","journal-title":"Nature Reviews. Genetics"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185792","article-title":"One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation","volume":"12","author":"Moruzzi","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0725","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/s41598-020-60409-4","article-title":"Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer","volume":"10","author":"Moufarrij","year":"2020","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0730","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ccr.2014.01.003","article-title":"UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma","volume":"25","author":"Mudbhary","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0735","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1101\/gr.108498.110","article-title":"LSH and G9a\/GLP complex are required for developmentally programmed DNA methylation","volume":"21","author":"Myant","year":"2011","journal-title":"Genome Research"},{"issue":"27","key":"10.1016\/j.pharmthera.2022.108334_bb0740","doi-asserted-by":"crossref","first-page":"24300","DOI":"10.1074\/jbc.M111.234104","article-title":"Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein","volume":"286","author":"Nady","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0745","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.ajpath.2014.07.005","article-title":"Contributions of hepatocytes and bile ductular cells in ductular reactions and remodeling of the biliary system after chronic liver injury","volume":"184","author":"Nagahama","year":"2014","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0750","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ijc.26061","article-title":"Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage","volume":"129","author":"Nagashio","year":"2011","journal-title":"International Journal of Cancer"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108334_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205864","article-title":"Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma","volume":"13","author":"Nakamoto","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061111","article-title":"Aberrant DNA methylation as a biomarker and a therapeutic target of cholangiocarcinoma","volume":"18","author":"Nakaoka","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0765","first-page":"4145","article-title":"Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma","volume":"17","author":"Nanok","year":"2018","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0770","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinre.2015.07.006","article-title":"TERT promoter mutations in primary liver tumors","volume":"40","author":"Nault","year":"2016","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007362","article-title":"Cancer epigenetics: Moving forward","volume":"14","author":"Nebbioso","year":"2018","journal-title":"PLoS Genetics"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0780","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/hep.25706","article-title":"Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma","volume":"56","author":"Nishida","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0785","first-page":"E71","article-title":"Dysregulated YAP1\/TAZ and TGF-beta signaling mediate hepatocarcinogenesis in Mob1a\/1b-deficient mice","volume":"113","author":"Nishio","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7470","key":"10.1016\/j.pharmthera.2022.108334_bb0790","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature12488","article-title":"Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication","volume":"502","author":"Nishiyama","year":"2013","journal-title":"Nature"},{"issue":"7154","key":"10.1016\/j.pharmthera.2022.108334_bb0795","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nature05987","article-title":"DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA","volume":"448","author":"Ooi","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0800","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.trecan.2019.05.002","article-title":"Epigenome remodeling in cholangiocarcinoma","volume":"5","author":"O\u2019Rourke","year":"2019","journal-title":"Trends Cancer"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0805","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/embor.2009.218","article-title":"Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain","volume":"10","author":"Otani","year":"2009","journal-title":"EMBO Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0810","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.11.024","article-title":"Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape","volume":"64","author":"Page","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0815","article-title":"Pathogenesis of primary liver carcinomas","volume":"1-2","author":"Paradis","year":"2022","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0820","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/jpet.121.000758","article-title":"5-Aza-4\u2032-thio-2\u2032-deoxycytidine, a new orally bioavailable nontoxic \u201cbest-in-class\u201d: DNA methyltransferase 1-depleting agent in clinical development","volume":"379","author":"Parker","year":"2021","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0825","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrm3589","article-title":"TETonic shift: Biological roles of TET proteins in DNA demethylation and transcription","volume":"14","author":"Pastor","year":"2013","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108334_bb0830","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1111\/jcmm.16615","article-title":"Transcriptome and DNA methylation analysis reveals molecular mechanisms underlying intrahepatic cholangiocarcinoma progression","volume":"25","author":"Peng","year":"2021","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"6290","key":"10.1016\/j.pharmthera.2022.108334_bb0835","doi-asserted-by":"crossref","first-page":"aad9780","DOI":"10.1126\/science.aad9780","article-title":"Epigenetic balance of gene expression by polycomb and COMPASS families","volume":"352","author":"Piunti","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0840","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/17435390.2020.1723730","article-title":"Effect of titanium dioxide nanoparticles on DNA methylation in multiple human cell lines","volume":"14","author":"Pogribna","year":"2020","journal-title":"Nanotoxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0845","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","article-title":"Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet","volume":"51","author":"Pogribny","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0850","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/1533034617748090","article-title":"DNA methylation markers improve the sensitivity of endoscopic retrograde cholangiopancreatography-based brushing cytology in extrahepatic cholangiocarcinoma","volume":"16","author":"Prachayakul","year":"2017","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"38","key":"10.1016\/j.pharmthera.2022.108334_bb0855","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1021\/bi8011725","article-title":"CXXC domain of human DNMT1 is essential for enzymatic activity","volume":"47","author":"Pradhan","year":"2008","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb0860","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/cr.2015.72","article-title":"DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination","volume":"25","author":"Qin","year":"2015","journal-title":"Cell Research"},{"issue":"7663","key":"10.1016\/j.pharmthera.2022.108334_bb0865","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature23015","article-title":"Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration","volume":"547","author":"Raven","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0870","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0875","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41467-018-04456-6","article-title":"Postnatal DNA demethylation and its role in tissue maturation","volume":"9","author":"Reizel","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0880","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.sbi.2018.06.004","article-title":"Detecting and interpreting DNA methylation marks","volume":"53","author":"Ren","year":"2018","journal-title":"Current Opinion in Structural Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0885","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1053\/j.gastro.2013.08.055","article-title":"Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma","volume":"145","author":"Revill","year":"2013","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0890","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1101\/gad.220467.113","article-title":"Multivalent histone engagement by the linked tandem Tudor and PHD domains of UHRF1 is required for the epigenetic inheritance of DNA methylation","volume":"27","author":"Rothbart","year":"2013","journal-title":"Genes & Development"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0895","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nsmb.2391","article-title":"Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation","volume":"19","author":"Rothbart","year":"2012","journal-title":"Nature Structural & Molecular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb0900","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-Demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0905","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/77023","article-title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci","volume":"25","author":"Rountree","year":"2000","journal-title":"Nature Genetics"},{"issue":"5456","key":"10.1016\/j.pharmthera.2022.108334_bb0910","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.287.5456.1253","article-title":"Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery","volume":"287","author":"Rudolph","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb0915","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.30270","article-title":"Hepatocyte-specific beta-catenin deletion during severe liver injury provokes cholangiocytes to differentiate into hepatocytes","volume":"69","author":"Russell","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb0920","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","article-title":"Wnt\/beta-catenin signaling in liver development, homeostasis, and pathobiology","volume":"13","author":"Russell","year":"2018","journal-title":"Annual Review of Pathology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0925","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ijc.11127","article-title":"Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas","volume":"105","author":"Saito","year":"2003","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0930","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/jhep.2001.22507","article-title":"Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis","volume":"33","author":"Saito","year":"2001","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108334_bb0935","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/cas.12732","article-title":"Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer","volume":"106","author":"Sakamoto","year":"2015","journal-title":"Cancer Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0940","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1478-3231.2007.01624.x","article-title":"Epigenetic DNA hypermethylation in cholangiocarcinoma: Potential roles in pathogenesis, diagnosis and identification of treatment targets","volume":"28","author":"Sandhu","year":"2008","journal-title":"Liver International"},{"issue":"7704","key":"10.1016\/j.pharmthera.2022.108334_bb0945","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41586-018-0075-5","article-title":"De novo formation of the biliary system by TGFbeta-mediated hepatocyte transdifferentiation","volume":"557","author":"Schaub","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb0950","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression","volume":"25","author":"Segovia","year":"2019","journal-title":"Nature Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb0955","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00277-022-04853-4","article-title":"A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes","volume":"101","author":"Sekeres","year":"2022","journal-title":"Annals of Hematology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108334_bb0960","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI63065","article-title":"Intrahepatic cholangiocarcinoma can arise from notch-mediated conversion of hepatocytes","volume":"122","author":"Sekiya","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0965","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-019-09713-w","article-title":"A DNMT3A PWWP mutation leads to methylation of bivalent chromatin and growth retardation in mice","volume":"10","author":"Sendzikaite","year":"2019","journal-title":"Nature Communications"},{"issue":"7171","key":"10.1016\/j.pharmthera.2022.108334_bb0970","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nature06397","article-title":"The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA","volume":"450","author":"Sharif","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb0975","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.25569","article-title":"Genome-wide DNA methylation profiles in hepatocellular carcinoma","volume":"55","author":"Shen","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb0980","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/epi.23062","article-title":"Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips","volume":"8","author":"Shen","year":"2013","journal-title":"Epigenetics"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb0985","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jmoldx.2012.01.014","article-title":"Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity","volume":"14","author":"Shin","year":"2012","journal-title":"The Journal of Molecular Diagnostics"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0990","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb0995","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.31437","article-title":"Attenuating the epidermal growth factor receptor-extracellular signal-regulated kinase-sex-determining region Y-box 9 axis promotes liver progenitor cell-mediated liver regeneration in zebrafish","volume":"73","author":"So","year":"2021","journal-title":"Hepatology"},{"issue":"6020","key":"10.1016\/j.pharmthera.2022.108334_bb1000","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1195380","article-title":"Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation","volume":"331","author":"Song","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055761","article-title":"Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/1078-0432.CCR-18-0284","article-title":"Combined CDK4\/6 and Pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma","volume":"25","author":"Song","year":"2019","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb1015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","article-title":"Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation","volume":"75","author":"Song","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb1020","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/bjc.2011.102","article-title":"CpG-island methylation study of liver fluke-related cholangiocarcinoma","volume":"104","author":"Sriraksa","year":"2011","journal-title":"British Journal of Cancer"},{"issue":"51","key":"10.1016\/j.pharmthera.2022.108334_bb1025","first-page":"E10981","article-title":"Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden","volume":"114","author":"Stone","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb1035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41419-022-04895-6","article-title":"DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"5929","key":"10.1016\/j.pharmthera.2022.108334_bb1040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108334_bb1045","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1073\/pnas.1019629108","article-title":"Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1)","volume":"108","author":"Takeshita","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb1050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.47.5.721","article-title":"Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver","volume":"47","author":"Tannapfel","year":"2000","journal-title":"Gut"},{"issue":"14","key":"10.1016\/j.pharmthera.2022.108334_bb1055","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1073\/pnas.1017000108","article-title":"Lsh, chromatin remodeling family member, modulates genome-wide cytosine methylation patterns at nonrepeat sequences","volume":"108","author":"Tao","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb1060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00280-014-2503-z","article-title":"Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4\u2032-thio-2\u2032-deoxycytidine and 5-aza-4\u2032-thio-2\u2032-deoxycytidine","volume":"74","author":"Thottassery","year":"2014","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb1065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2019.11.021","article-title":"MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR\/PI3K\/AKT pathways","volume":"72","author":"Tiemin","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40169-019-0230-0","article-title":"Epigenetics of hepatocellular carcinoma","volume":"8","author":"Toh","year":"2019","journal-title":"Clinical and Translational Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108334_bb1075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2010.08.021","article-title":"Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis","volume":"54","author":"Um","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/nar\/gky947","article-title":"DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells","volume":"47","author":"Veland","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb1085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.27732","article-title":"DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma","volume":"61","author":"Villanueva","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb1090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm3274","article-title":"Understanding the language of Lys36 methylation at histone H3","volume":"13","author":"Wagner","year":"2012","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1095","article-title":"The epigenetic regulation of microenvironment in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fmolb.2015.00013","article-title":"Methylation of cell-free circulating DNA in the diagnosis of cancer","volume":"2","author":"Warton","year":"2015","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13148-019-0634-0","article-title":"Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases","volume":"11","author":"Wasenang","year":"2019","journal-title":"Clinical Epigenetics"},{"issue":"21","key":"10.1016\/j.pharmthera.2022.108334_bb1110","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1158\/0008-5472.CAN-06-2130","article-title":"Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression","volume":"66","author":"Wehbe","year":"2006","journal-title":"Cancer Research"},{"issue":"14","key":"10.1016\/j.pharmthera.2022.108334_bb1115","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/onc.2016.340","article-title":"A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets","volume":"36","author":"Wijetunga","year":"2017","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb1120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41588-022-01119-7","article-title":"YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis","volume":"54","author":"Wu","year":"2022","journal-title":"Nature Genetics"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2022.108334_bb1130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2013.12.019","article-title":"Reversing DNA methylation: Mechanisms, genomics, and biological functions","volume":"156","author":"Wu","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb1135","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7080213","article-title":"Molecular targets in hepatocarcinogenesis and implications for therapy","volume":"7","author":"Wu","year":"2018","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1140","doi-asserted-by":"crossref","first-page":"8435420","DOI":"10.1155\/2020\/8435420","article-title":"Overexpression of 14-3-3delta predicts poor prognosis in extrahepatic cholangiocarcinoma patients","volume":"2020","author":"Wu","year":"2020","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7819-10-5","article-title":"Correlation between promoter methylation of p14(ARF), TMS1\/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma","volume":"10","author":"Xiaofang","year":"2012","journal-title":"World Journal of Surgical Oncology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108334_bb1150","doi-asserted-by":"crossref","DOI":"10.3390\/genes9120600","article-title":"The growing complexity of UHRF1-mediated maintenance DNA methylation","volume":"9","author":"Xie","year":"2018","journal-title":"Genes (Basel)"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108334_bb1155","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41419-022-05279-6","article-title":"HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway","volume":"13","author":"Xiong","year":"2022","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41467-018-08245-z","article-title":"Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming","volume":"10","author":"Xiong","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1165","article-title":"Apolipoprotein B is associated with the microenvironment of cholangiocarcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb1170","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.molcel.2011.04.005","article-title":"Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells","volume":"42","author":"Xu","year":"2011","journal-title":"Molecular Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb1175","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cell.2012.11.014","article-title":"Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development","volume":"151","author":"Xu","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb1180","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s13402-021-00642-9","article-title":"Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt\/beta-catenin signaling and inhibits apoptosis in cholangiocarcinoma","volume":"44","author":"Xue","year":"2021","journal-title":"Cellular Oncology (Dordrecht)"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108334_bb1185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.3800287","article-title":"Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma","volume":"18","author":"Yang","year":"2005","journal-title":"Modern Pathology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb1190","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/hep4.1730","article-title":"DNA methylation markers for detection of cholangiocarcinoma: Discovery, validation, and clinical testing in biliary brushings and plasma","volume":"5","author":"Yang","year":"2021","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108334_bb1195","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1101\/gad.207803.112","article-title":"Robust cellular reprogramming occurs spontaneously during liver regeneration","volume":"27","author":"Yanger","year":"2013","journal-title":"Genes & Development"},{"issue":"50","key":"10.1016\/j.pharmthera.2022.108334_bb1200","doi-asserted-by":"crossref","first-page":"19466","DOI":"10.1074\/jbc.RA118.004612","article-title":"BAH domains and a histone-like motif in DNA methyltransferase 1 (DNMT1) regulate de novo and maintenance methylation in vivo","volume":"293","author":"Yarychkivska","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108334_bb1205","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","article-title":"Hippo pathway activity influences liver cell fate","volume":"157","author":"Yimlamai","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108334_bb1210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13577-022-00683-8","article-title":"SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury","volume":"35","author":"Yoshii","year":"2022","journal-title":"Human Cell"},{"issue":"5980","key":"10.1016\/j.pharmthera.2022.108334_bb1215","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1186366","article-title":"Genome-wide evolutionary analysis of eukaryotic DNA methylation","volume":"328","author":"Zemach","year":"2010","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108334_bb1220","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.21873\/invivo.12868","article-title":"Cyclin-dependent kinase 4\/6 inhibitors: A potential breakthrough therapy for malignancies of gastrointestinal tract","volume":"36","author":"Zeng","year":"2022","journal-title":"In Vivo"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-015-0056-6","article-title":"Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"7","author":"Zeybel","year":"2015","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/j.pharmthera.2022.108334_bb1230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biocel.2018.09.003","article-title":"Fresh red raspberry phytochemicals suppress the growth of hepatocellular carcinoma cells by PTEN\/AKT pathway","volume":"104","author":"Zhang","year":"2018","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108334_bb1235","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082123","article-title":"DNA methyltransferases in cancer: Biology, paradox, aberrations, and targeted therapy","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.pharmthera.2022.108334_bb1240","first-page":"6784","article-title":"lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression","volume":"22","author":"Zhang","year":"2018","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"13","key":"10.1016\/j.pharmthera.2022.108334_bb1245","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1093\/nar\/gkq147","article-title":"Chromatin methylation activity of Dnmt3a and Dnmt3a\/3L is guided by interaction of the ADD domain with the histone H3 tail","volume":"38","author":"Zhang","year":"2010","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108334_bb1250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13148-019-0733-y","article-title":"DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma","volume":"11","author":"Zheng","year":"2019","journal-title":"Clinical Epigenetics"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822002285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822002285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:32:37Z","timestamp":1759012357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822002285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":248,"alternative-id":["S0163725822002285"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108334","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation in cell plasticity and malignant transformation in liver diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108334"}}